ArticleBMC genomics2026
Uncovering the transcriptional landscape of estrogen-induced gonadal feminization in the Chinese giant salamander.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exogenous estrogen (17β-estradiol, E2) induces partial sex reversal in the Chinese giant salamander (CGS) at low concentrations (25 µg/L), and complete sex reversal at high concentrations (1000 µg/L), suggesting potential risks of skewed sex ratios in wild populations of this critically endangered species. Simultaneously, controlled sex reversal offers a strategy to enhance the aquaculture efficiency of captive CGS. However, the molecular mechanisms underlying this process remain largely unexplored. Here, we generated histological evidence of male-to-female sex reversal in CGS under E2 treatment and characterized dynamic, multi-timepoint transcriptomic changes during this process. Integrating histological and transcriptomic data, we identified 210 days post-hatching (120 days after hormone treatment) as a critical window for male gonadal sex reversal. During this period, E2 upregulates meiosis-related genes, promoting and maintaining the transition from male to female gonads. Concurrently, E2 suppresses DMRT1 expression, inhibiting male-specific differentiation pathways and facilitating testicular feminization. Notably, early E2 exposure increases CYP19A expression, but as E2 accumulates, it gradually supplants role of CYP19A in hormone-mediated regulation, resulting in a progressive decline of CYP19A function in gonads. These findings provide a comprehensive molecular and histological framework for understanding E2-induced sex reversal in CGS, offering crucial insights for the conservation of wild populations and for improving aquaculture practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.